Despite numerous studies investigating visfatin and chemerin separately in metabolic disorders, few have simultaneously evaluated these adipokines in both obese and non-obese patients with T2DM within the same cohort. The gene discussed is NAMPT; the disease is type 2 diabetes mellitus.